Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Texas was posted on July 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

HHS0017640 DNA Extraction Reagents Newborn Screening

Closed
HHS0017640State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
DIBBS
TEST KIT, CORONAVIRUS D
Solicitation # SPE2DS-26-T-379Q
Solicitation SPE2DS-26-T-379Q, issued by the DLA Troop Support Medical Supply Chain, is a request for quotes for Abbott BinaxNOW COVID-19 Antigen test kits designed for over-the-counter, at-home use. The requirement consists of three line items, each for one case containing 12 kits with two tests per kit, under NSN 6550-01-716-1573. Delivery is required within five days after the order date, with an original required delivery date of September 2, 2026, to destinations including the SS Preble DDG 88 and USS Princeton CG 59. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of government delivery. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the manufacture date, expiration or retest date, and the contract or lot number. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001 for palletization. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for invoicing and compliance with the Buy American Act, Berry Amendment, and NIST SP 800-171 assessment requirements. Quotes must be submitted via DLA DIBBS by September 8, 2026.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

3 days ago

DEADLINE

in 6 days
NAICS: 325413
New
Federal
BPA - Laboratory Supplies/Reagents - Crownpoint Healthcare Facility
Solicitation # 75H71026Q00179
Solicitation 75H71026Q00179 is a Request for Quotation issued by the Navajo Area Indian Health Service under the Department of Health and Human Services to establish a Blanket Purchase Agreement for the Crownpoint Healthcare Facility Laboratory in New Mexico. The contract scope involves the provision of laboratory supplies, reagents, diagnostic test kits, collection supplies, quality control materials, and related consumables. These items will be ordered on an as-needed basis to support patient care and diagnostic services. The requirement is a 100% set-aside for Indian Small Business Economic Enterprises under the Buy Indian Act, requiring offerors to self-certify their eligibility as an Indian Economic Enterprise per HHSAR 326.601 and maintain an active registration in the System for Award Management. The period of performance consists of a base period from October 1, 2026, through September 30, 2027, with a subsequent option period running from October 1, 2027, through September 30, 2028. Delivery is specified as FOB Destination to the Crownpoint Healthcare Facility. While manufacturer names and part numbers are provided for identification, equivalent products may be offered subject to technical acceptability. Offerors must submit their quotations by September 10, 2026, and are expected to provide a full-line laboratory supply catalog. Compliance with the Buy Indian Act is mandatory throughout the entire term of the contract, with strict legal penalties applicable for false representations regarding enterprise status.
Navajo Area Indian Health Svc

POSTED

3 days ago

DEADLINE

in 7 days

AI Contract Overview

Show more

The Texas Department of State Health Services is soliciting bids for a five-year contract to supply DNA extraction reagents essential for the state’s Newborn Screening Program, specifically to support screening for Severe Combined Immunodeficiency Disorder and Spinal Muscular Atrophy using dried blood spot samples. The contract requires two specific reagents: QuantaBio Extracta DBS DNA extraction buffer at 1x concentration, part number 95171-500 in 500 mL units, estimated at 450 units annually, and QuantaBio PerfeCTa qPCR ToughMix UNG, Low ROX at 2x concentration, part number 95140-05K in 50 mL units, estimated at 136 units annually. All products must meet exact technical specifications, and any proposed substitutions must be accompanied by sufficient documentation demonstrating equivalency or superior performance; bids lacking this documentation will be disqualified. Products must be shipped as single lots, remain free of rework, seconds, or previously refused items, and be packaged to maintain manufacturer-specified temperature conditions during transit. Deliveries must be complete, with no mixing of brands or split shipments unless explicitly requested, and must arrive on time according to HHSC’s schedule. The contract has an initial term from September 1, 2026, through August 31, 2027, with up to four optional one-year renewals extending through August 31, 2031, and a potential one-year extension beyond that. Bids must be submitted via email, the HHS Online Bid Room, or hand-delivered on a USB drive by the deadline of July 15, 2026, at 10:30 AM CT; late responses are not accepted. All submissions must be in Microsoft Office or Adobe PDF formats, and responses submitted by fax or unauthorized methods will be rejected. Bidders must provide their SAM.gov Unique Entity Identifier, Federal Employer Identification Number, Texas Identification Number, Texas Franchise Tax Number, and Texas Secretary of State Filing Number, and must certify they are not suspended, debarred, or ineligible under state or federal law, including compliance with civil rights statutes like Title VI and Section 504 of the Rehabilitation Act. Pricing must be firm, fixed, and all-inclusive, covering labor, materials, and associated costs, with no additional charges permitted on invoices. Payment is governed by the Texas Prompt Payment Act, requiring

General Info

Five-year contract for DNA reagents to support Texas newborn SCID-SMA testing, bids due July 15, 2026.

Agency

Texas → Department of State Health Services

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

TX, USA

Set-Aside

NONE

Documents

(6)

HHS Contract Affirmations Exhibit B PCS 111

PDFcontract-affirmations

HHS0017640 Exhibit D-1 PCS Map Directions

PDFother

HHS Solicitation Affirmations Exhibit A v2.9

PDFsolicitation-affirmations

HHS0017640 Exhibit C Pricing Sheet

XLSpricing-sheet

IFB HHS0017640 DNA Extraction Reagents for Newborn Screening

PDFifb

HHS Online Bid Room Information HHS0017209v2

PDFspecial-notice

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyTexas → Department of State Health Services
Contacts1 person available
OfficeTX, USA
Organization / Agency
Texas → Department of State Health Services
Office AddressTX, USA

Full Description

Show more
The Texas Department of State Health Services (DSHS) is currently accepting bids for a Five(5) Year contract for DNA Extraction Reagents for Newborn Screening Program. Testing supplies needed to continue SCID-SMA Screening as part of the Newborn Screening Program. Bidders offering alternatives to the specified brand must submit adequate literature with their bid to facilitate item evaluation. Bids lacking this literature may be disqualified from consideration. All products must conform to the stated minimum specifications.